Am Surg8 Apr 2024
Researchers successfully performed laparoscopic total gastrectomy in two cases of remnant gastric cancer using intraoperative indocyanine green fluorescence imaging. The technique allowed visualization of the liver and common bile duct, leading to safe dissection of severe adhesions between hepatobiliary organs and the remnant stomach. This…
J Gastrointest Surg5 Apr 2024
Study comparing total and proximal gastrectomy for proximal gastric cancer found that more patients underwent proximal gastrectomy, with a higher likelihood of receiving neoadjuvant chemotherapy. Pathologically, total gastrectomy patients had more advanced tumors and fewer evaluated lymph nodes, but lower margin negativity. Long-term survival did…
J Gastrointest Surg5 Apr 2024
Patients with preoperative anemia undergoing curative-intent resection for gastroenteropancreatic neuroendocrine tumors (GEP-NETs) had higher rates of major complications and poorer long-term outcomes. Anemia was associated with worse overall survival, while postoperative transfusions were linked to lower overall survival and recurrence-free survival rates. Preoperative anemia affected…
J Gastrointest Surg5 Apr 2024
Implementation of enhanced recovery after surgery (ERAS) protocol in distal gastrectomy for gastric cancer significantly reduces adjusted hospital stay without increasing complications. However, no significant differences were observed in long-term nutritional outcomes and quality of life between ERAS and conventional care groups
Eur J Surg Oncol5 Apr 2024
In a comparative study of endoscopic therapy (ET) versus surgical resection for 2-5 cm gastrointestinal stromal tumors, long-term outcomes showed no significant difference in overall or cancer-specific survival rates. After propensity score matching, both groups had comparable survival rates, suggesting that ET may be a…
Ann Surg Oncol4 Apr 2024
A potent nomogram incorporating tumor budding accurately predicts lymph node involvement in early gastric cancer patients, providing exceptional discriminative power and precise predictive capabilities. Tumor budding, along with other clinicopathological factors, demonstrated a robust association with lymph node involvement, improving clinical decision-making by reducing the…
BMC Surg4 Apr 2024
Comparing modified Billroth-II with hinged anti-peristaltic afferent loop and Roux-en-Y reconstruction after distal gastrectomy for gastric cancer, the former showed superior outcomes in terms of operating time, postoperative hospital stays, and time to semi-solid diet tolerance. However, both methods had similar functional outcomes. The study…
Ann Surg Oncol3 Apr 2024
Patients with locally advanced esophageal adenocarcinoma who received neoadjuvant immunotherapy (io) combined with chemotherapy showed similar perioperative outcomes compared to those who received neoadjuvant chemotherapy alone. Rates of overall and major complications, anastomotic leak, respiratory complications, hospital stay length, and mortality were comparable between the…
Ann Surg Oncol3 Apr 2024
Patients younger than 50 years, of non-white race, with annual income
Surg Endosc3 Apr 2024
Most gastric leiomyomas are benign subepithelial tumors, with few becoming symptomatic or increasing in size. A retrospective review of 231 cases showed that only 2.4% experienced size increase, one of which was leiomyosarcoma. The majority remained stable, with resections confirming leiomyoma. Close monitoring may be…